May 2018

Opioid use, abuse, and associated deaths have skyrocketed in the United States over the past decade. Since 1999, the number of opioid-related deaths has quadrupled

Among the most important initiatives affecting health systems in the United States in 2017 was The Joint Commission (TJC) mandate requiring antimicrobial stewardship (AMS) programs at all acute-care and critical-access hospitals in the country.

The capecitabine and warfarin interaction is well documented in the literature and has earned a black box warning because of its potential severity.

In this issue of Pharmacy Times® Health-System Edition, Grayson K. Peek, PharmD, and Halena Leah Marcelin, PharmD, offer a brief discussion of optimizing wholesale acquisition cost exposure for organizations participating in the federal 340B drug discount program when the group purchasing organization prohibition requirement applies.